Remote Preclinical R&D Expert — Drug Development

mercor; France; Remote; EUR 74,000 - 123,000; Part time

Job summary

Mercor seeks a Preclinical R&D Expert for in-house drug development on a contract basis. The role is remote with a commitment of 10 hours per week and compensation of $60–$100/hour.

You will review technical materials, annotate data, and provide expert input on target and modality decisions to guide development. The candidate should have hands-on preclinical R&D experience across multiple functions and drug modalities, with 5+ years in the industry.

Qualifications

• Hands-on, non-administrative preclinical R&D experience.
• Experience in discovery biology, medicinal chemistry, protein/antibody engineering, computational, in vivo/translational, pharmacology/PK‑PD, toxicology, or CMC/formulation.
• Hands-on experience with one or more drug modalities: small molecules, monoclonal antibodies, peptides, ADCs, etc.
• 5+ years of relevant industry R&D experience.

Responsibilities

• Review technical materials and real‑world R&D data in your area of expertise.
• Label, classify, and annotate scientific data and model outputs to improve model performance.
• Provide expert perspective on key scientific and development decisions, including target/modality selection and optimization.
• Help define structure and quality standards for the client's dataset pipeline .
• Participate in expert discussions, interviews, and research engagements.
• Interface directly with the client team to ensure alignment and progress.

Skills

Preclinical R&D

Data annotation

Target/modality selection

5+ years R&D

Job description

Mercor seeks a Preclinical R&D Expert for in-house drug development on a contract basis. The role is remote with a commitment of 10 hours per week and compensation of $60–$100/hour.

You will review technical materials, annotate data, and provide expert input on target and modality decisions to guide development. The candidate should have hands-on preclinical R&D experience across multiple functions and drug modalities, with 5+ years in the industry.